[New therapeutic aspects in Kawasaki syndrome and personal experiences].
Kawasaki disease is an inflammatory disease of unknown etiology. The prognosis depends mainly on cardiac, mostly coronary involvement which can be significantly reduced with the use of immunoglobulins. The current recommended therapy consists of a single dose of immunoglobulins (2 g/kg i.v.) combined with acetylsalicylic acid. During 1984-1992 we diagnosed Kawasaki disease in 35 patients. Three of them not treated with immunoglobulins developed coronary aneurysms.
Klinik und Poliklinik für Kinder- und Jugendmedizin, Universität Essen, BRD.
U
U
Neudorf
D001241:Aspirin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007116:Immunization, Passive; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000276:immunology / Q000628:therapy*; D011241:Prednisone / Q000008:administration & dosage
D001241:Aspirin; D011241:Prednisone
Neue therapeutische Aspekte zum Kawasaki-Syndrom und eigene Erfahrungen.